发明名称 USE OF GELSOLINE FOR THERAPIES OF MULTIPLE SCLEROSIS AND DIAGNOSIS OF NEUROLOGIC DISEASES
摘要 <P>PROBLEM TO BE SOLVED: To provide use of gelsoline for therapies of neurologic diseases such as multiple sclerosis, and use of gelsoline for diagnosis and observation of neurologic diseases and evaluation of therapies of neurologic diseases. <P>SOLUTION: A method to characterize a risk profile of developing neurologic diseases of a subject in the future includes obtaining a gelsoline level of the subject, comparing the gelsoline level with a predetermined value, and characterizing the risk profile of developing a neurologic disease of the subject based on the gelsoline level compared to the predetermined value. A gelsoline level equal to or lower than the predetermined level indicates that the subject has a high risk of developing the neurologic disease, while a gelsoline level equal to or higher than the predetermined level indicates that the subject does not have a high risk of developing the neurologic disease. <P>COPYRIGHT: (C)2012,JPO&INPIT
申请公布号 JP2012053071(A) 申请公布日期 2012.03.15
申请号 JP20110271607 申请日期 2011.12.12
申请人 BRIGHAM & WOMEN'S HOSPITAL INC;BLOODCENTER RESEARCH FOUNDATION INC 发明人 THOMAS P STOSEL;PO-SHUN LEE;DITTEL BONNIE;KATARZYNA MARESZ
分类号 G01N33/68;A61K31/136;A61K31/198;A61K31/421;A61K31/519;A61K31/52;A61K31/565;A61K31/57;A61K31/573;A61K31/65;A61K31/675;A61K31/7076;A61K31/712;A61K38/00;A61K38/21;A61K38/22;A61K38/35;A61K39/07;A61K39/395;A61K45/00;A61P25/00 主分类号 G01N33/68
代理机构 代理人
主权项
地址